International Journal of Cardiovascular ResearchISSN: 2324-8602

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Daniel Alejandro Lerman Author

Subjects of specialization
Aortic valve calcification disease, Aortic valve interstitial cells

Affiliation
Department of Cardiothoracic Surgery, Royal Infirmary Hospital of Edinburgh(NHS Lothian) The University of Edinburgh, United Kingdom

Biography

Department of Cardiothoracic Surgery, Royal Infirmary Hospital of Edinburgh(NHS Lothian) The University of Edinburgh, United Kingdom  Denosumab is a fully human monoclonal antibody and novel antiresorptive agent that works by binding receptor activator of nuclear factor kappa-β ligand (RANKL) and inhibiting the signaling cascade that causes osteoclast maturation, activity, and survival. 


Publications

Research Article Open Access

Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro

Author(s):

Daniel Alejandro Lerman, Sai Prasad and Nasri Alotti

Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro

Objective: Denosumab is a fully human monoclonal antibody and novel antiresorptive agent that works by binding receptor activator of nuclear factor kappa-β ligand (RANKL) and inhibiting the signaling cascade that causes osteoclast maturation, activity, and survival. We aimed to elucidate the effect of Denosumab in the process of spontaneous and induced calcification in an in vitro porcine valvular interstitial cells (VICs) model.

Materials and Methods: VICs were extracted from fresh porcine hea... view moreĀ»

DOI: 10.4172/2324-8602.1000249

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP